Patients ( n = 337 ) in this 36 week study ( 10 week acute and 26 week extension treatment ) received duloxetine ( 60-120mg once daily [ QD ] , n = 117 ) , fluoxetine ( 20-40mg QD , n = 117 ) , or placebo ( n = 103 ) .